C&EN Whitepaper
Enhancing Drug Discovery Research with AI
Brought to you by NVIDIA

Pharmaceutical companies and researchers pour years of effort and billions of dollars into drug design and development. At every phase of drug discovery, see how artificial intelligence is accelerating workflows to cut costs, save time, and enable new drugs going to market faster than ever before.

Learn about how AI is enhancing protein structure determination, chemoinformatics, molecular simulations, and more in this industry brief.

Key Objectives:

Learn how NVIDIA GPUs AI-powered drug discovery efforts are enabling pharmaceutical and biotechnology companies to streamline research and development methods across:

  • Genomics
  • Protein Structure Determination
  • Cheminformatics
  • Simulations in Drug Discovery

Brought to you by:
Please complete the form to download the whitepaper.
*By filling out the form, you agree to share your data with our partner, NVIDIA. Your information will be handled in accordance with NVIDIA's Privacy Policy .

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) via email, in accordance with the ACS Privacy Policy .

Copyright © 2024 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy